1Dykins R,Corbett IP,Henry JA,et al.Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11 [J].J Pathol,1991,163: 105-110.
2Tateishi M,Ishida T,Kohdono S,et al.prognostic influece of the coexpression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma [J].Surg 0ncol,1994,3(2): 109-113.
3Iggo R,Gatter K,Bartek J,et al.Increased expression of mutant froms of p53 oncogene in primary lung cancer [J].Lancel,1990,335: 675-679.
5Maruyama R,Sugio K,Fukuyama Y,et al.Evaluation of p53 alterations in occult lymph node metastases [J].J Surg Oncol,2000,73(3): 143-147.
6Walker C,Robertson LJ,Myskow MW,et al.p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas [J].Br J Cancer,1994,70: 297-303.
6SCHWARTZ D,ROTTER V.p53-dependent cell cycle control:response to genotoxic stress[In Process Citation][J].Cancer Biol,1998,8(5):325-336.
7SEARS R C,NEVINS J R.Signaling networks that link cell proliferation and cell fate.J Bid Chem,2002,277(14):11617-11620.
8WU X,ZHAO H,AMOS C I,et al.p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity[J].J Natl Cancer Inst,2002,94(9):681-690.
9HIYAMA T,TAMAKA S,KITADAI Y,et al.p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis[J].Int J Cancer,2002,100(3):304 -308.
10SIORIS T,HUSGAFVEL PURSIAINEN K,ARJALAINEN A,et al.Survival in operable non-small-cell lung cancer:role of p53 mutations,tobacco smoking and asbestos exposure[J].Int Cancer,2000,86(4):590-594.
